Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Yan Jiang,1,* Zhen-Lin Zhang,2,* Zhong-Lan Zhang,3 Han-Min Zhu,4 Yi-Yong Wu,5 Qun Cheng,4 Feng-Li Wu,5 Xiao-Ping Xing,1 Jian-Li Liu,3 Wei Yu,6 Xun-Wu Meng11Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijin...

Full description

Bibliographic Details
Main Authors:	Jiang Y, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-01-01
Series:	Clinical Interventions in Aging
Subjects:	menatetrenone alfacalcidol postmenopausal osteoporosis mineral bone density undercarboxylated osteocalcin
Online Access:	https://www.dovepress.com/menatetrenone-versus-alfacalcidol-in-the-treatment-of-chinese-postmeno-peer-reviewed-article-CIA

Similar Items

Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes
by: Shogo Funakoshi, et al.
Published: (2020-08-01)

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
by: Mori Katsuhito, et al.
Published: (2012-12-01)

Evaluation of Serum Osteocalcin Level in Iraqi Postmenopausal Women with Primary Osteoporosis
by: Rana A. Hamdi
Published: (2013-07-01)

The role of osteocalcin in regulation of glycolipid metabolism and muscle function in children with osteogenesis imperfecta
by: Wen-bin Zheng, et al.
Published: (2022-08-01)

Effect of alfacalcidol on bone regeneration in senile rats
by: F.V. Klymovytskyy, et al.
Published: (2022-12-01)

Bone turnover markers relations to postmenopausal osteoporosis
by: Mečevska-Jovčevska Jasmina, et al.
Published: (2009-01-01)

Associations of dietary vitamin K and bone markers in adult Saudi females
by: Samaher F. Alsadhan, et al.
Published: (2020-07-01)

Functional tooth number in the posterior region associated serum ucOC levels
by: Masahiko Nakamura, et al.
Published: (2022-11-01)

Yeast Hydrolysate and Postmenopausal Osteoporosis
by: Yang Hee Hong, et al.
Published: (2023-02-01)

Comparison of Paricalcitol (I.V) and Alfacalcidol (I.V) in Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients
by: Mansoor Abbas Qaisar, et al.
Published: (2020-12-01)

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study
by: Yang Xu, et al.
Published: (2022-07-01)

Osteocalcin and vascular function: is there a cross-talk?
by: Alexander Tacey, et al.
Published: (2021-07-01)

Evaluation of serum undercarboxylated osteocalcin in premenopausal rheumatoid arthritis patients: its correlation with disease activity and bone mineral density
by: Heba A Esaily, et al.
Published: (2016-01-01)

Intermittent Oral Versus Intravenous Alfacalcidol in Dialysis Patients
by: Mitwalli Ahmed, et al.
Published: (2000-01-01)

Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
by: Leila C. B. Zanatta, et al.

Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women – a pilot study
by: Selma Cvijetic, et al.
Published: (2016-03-01)

Association of Vitamin K Insufficiency as Evaluated by Serum Undercarboxylated Osteocalcin With Frailty in Community-Dwelling Older Adults
by: Kotaro Azuma, et al.
Published: (2022-04-01)

Evaluation of Serum Osteocalcin and Osteopontin Levels as Bone Biochemical Markers in Postmenopausal Women.
by: Kisma M Turki, et al.
Published: (2013-06-01)

ACTIVE VITAMIN D METABOLITES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
by: O. V. Yakushevskaya
Published: (2017-12-01)

Vitamin K to prevent fractures in older women: systematic review and economic evaluation
by: M Stevenson, et al.
Published: (2009-09-01)

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a
by: Hailong Wang, et al.
Published: (2021-03-01)

A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol
by: Noboru Kubodera
Published: (2009-09-01)

Anabolic Bone Stimulus Requires a Pre-Exercise Meal and 45-Minute Walking Impulse of Suprathreshold Speed-Enhanced Momentum to Prevent or Mitigate Postmenopausal Osteoporosis within Circadian Constraints
by: Qingyun Zheng, et al.
Published: (2021-10-01)

Serum Osteocalcin and Serum Osteopontin Levels in Osteoporotic Postmenopausal Women with and without Vertebral Fractures
by: Nawar S. Mohammed, et al.
Published: (2015-10-01)

Effect of 8-week Aerobic Exercise on Undercarboxylated Osteocalcin and Beta Cell Function in Postmenopausal Women
by: Asieh Abbassi Daloii, et al.
Published: (2016-11-01)

Serum osteocalcin and bone mineral density in postmenopausal women
by: Lie T. Merijanti Susanto
Published: (2011-12-01)

Serum osteocalcin and bone mineral density in postmenopausal women
by: Lie T. Merijanti Susanto
Published: (2016-02-01)

Impact of Osteocalcin Level on Vascular Calcification in Type 2 Diabetics in Relation to Fibroblast Growth Factor-23(FGF-23)
by: Inas A. Ali, et al.
Published: (2018-12-01)

Male subclinical hypogonadism and late-onset hypergonadotrophic hypogonadism: mechanisms, endothelial function, and interplay between reproductive hormones, undercarboxylated osteocalcin, and endothelial dysfunction
by: Ragaa Abedelshaheed Matta, et al.
Published: (2022-12-01)

Relationship Between Bone Turnover and Bone Density in Perimenopausal and Early Postmenopausal Women - Original Investigation
by: Nurdan Paker, et al.
Published: (2009-04-01)

Modern views on the etiology, pathogenesis, diagnosis, prevention and treatment of vitamin D deficiency in postmenopausal women (literature review)
by: T Yu Pestrikova, et al.
Published: (2016-02-01)

A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls
by: Zhongyu Liu, et al.
Published: (2019-11-01)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

Effects of the inclusion of alfacalcidol in complex rehabilitation programs for patients with age-related facial ptosis
by: O. A. Gromova, et al.
Published: (2021-01-01)

The Relationship Among Between Serum Cytokine, Intact PTH, Osteocalcin and Bone Mineral Density Values in Postmenopausal Women
by: M. Yıldız, et al.
Published: (2002-06-01)

Impact of Vitamin D Elements and Osteoporosis Factors in Postmenopausal Iraqi Women with T2DM
by: Howraa Alkabi, et al.
Published: (2022-09-01)

Association of Vitamin K Insufficiency With Cognitive Dysfunction in Community-Dwelling Older Adults
by: Kotaro Azuma, et al.
Published: (2022-01-01)

Impact of intercurrent illness on calcium homeostasis in children with hypoparathyroidism: a case series
by: A Chinoy, et al.
Published: (2017-10-01)

Study the Effect of Exercise on Bone Markers, Glycemic and Anthropometric Indices in Postmenopausal Women with Diabetes
by: Bahloul Ghorbanian, et al.
Published: (2017-04-01)

Efficiency of Ibandronate in Monotherapy and in Combination with Alfacalcidol in Women with Postmenopausal Osteoporosis
by: S.I. Ismailov, et al.
Published: (2016-09-01)